The share price reaction of Intra-Cellular Therapies was not as strong as expected after the positive phase 3 results of Caplyta in major depressive disorder.Positive MDD results represent another de-...
Source LinkThe share price reaction of Intra-Cellular Therapies was not as strong as expected after the positive phase 3 results of Caplyta in major depressive disorder.Positive MDD results represent another de-...
Source Link
Comments